AiViva Biopharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
COSTA MESA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Mr. Jung-Chin (Rongjin) Lin to its board of directors. He is Honorary President of Center Laboratories, Inc. and Chairman of the Board of Lumosa Therapeutics Co., Ltd. and Glac Biotech Co., Ltd. He also serves as a Board member at Adimmune Corp. and BioGend Therapeutics Co., Ltd